Best Selling Pharma Products in 2014-15

8/18/2019 Best Selling Pharma Products in 2014-15

1/23

Best Selling

Pharma Products

Prepared By:

Mrinal Patil (P-011)

Alay Joshi (P-008)ohit Patel (!-00")


2/23

GLOBAL PHARMA MARKETSCENARIO

• Global Pharmaceutical Market Report & Forecast:2012-2017” : The global pharmaceutical market isepecte! to gro" at a #$GR o% ' !uri(g 2011-2017ecee!i(g sales "orth )*+ 1,1 Trillio( b 2017,

• The research i!e(ti.es that sales o% ge(eric !rugs"ill emerge as the most promi(e(t segme(t o% the pharma market !uri(g the %orecast perio!/ i(!icati(glarge opportu(ities %or ge(erics ma(u%acturers ,

• *pe(!i(g o( me!ici(es "hich "as estimate! at +

billio( i( 2010/ is epecte! to reach (earl +1/100billio( i( 201/ reecti(g a slo"i(g gro"th rate o% 3' o4er the .4e ear perio! compare! to ,2 per ce(ta((ual gro"th o4er the past .4e ears2


3/23


4/23

#op 10 $lo%al

Pharma ProductsProducts Rank Growth Rate (%)

Humira 1 22.1

Lantus 2 30.4

Soa!di 3 "#.$4

&i!i' 4 1".2

n&re! * 11.0

Seretide $ +*.3

,restor - *.$

Remicade

# -.-

e/ium " +1.4a&ther 10 4.3


5/23

HUMIRA• Humira is used to treat rheumatoid arthritis, juvenile

idiopathic arthritis, psoriatic arthritis, ankylosingspondylitis, plaque psoriasis, and hidradenitis suppurativa.

• It is also used to treat Crohn's disease or ulcerative colitis

http://www.drugs.com/mcd/rheumatoid-arthritishttp://www.drugs.com/mcd/rheumatoid-arthritishttp://www.drugs.com/mcd/crohn-s-diseasehttp://www.drugs.com/mcd/ulcerative-colitishttp://www.drugs.com/mcd/ulcerative-colitishttp://www.drugs.com/mcd/ulcerative-colitishttp://www.drugs.com/mcd/crohn-s-diseasehttp://www.drugs.com/mcd/rheumatoid-arthritis


6/23

Lantus

2013 20140

2000

4000

$000

#000

10000

12000

#014

10331

Sa!es (S mi!!ion)


7/23


8/23

Abilify

• Abilify is used to treat the symptoms of psychotic conditions such asschizophrenia and bipolar disorder (manic depression). It is also usedtogether with other medications to treat major depressive disorder inadults


9/23

ENBRELEnbrel is used to treat te s!m"toms o# reumatoid

artritis "soriati% artritis or an&!losin' s"ond!litisand to "reent oint dama'e %aused b! tese

%onditions


10/23

Seretide

2011 2012 2013 20146500

7000

7500

80008500

9000

9500

7705

89079198

8652

Revenues in US million Dollars

*t is used to treatment o# astma and%roni% obstru%tie "ulmonar! disease (+,-.)/

https://en.wikipedia.org/wiki/Asthmahttps://en.wikipedia.org/wiki/Chronic_obstructive_pulmonary_diseasehttps://en.wikipedia.org/wiki/Chronic_obstructive_pulmonary_diseasehttps://en.wikipedia.org/wiki/Asthma


11/23

,RS78R

2011 2012 2013 20147900

8000

8100

8200

8300

8400

8500

8600

81368215

8140

8473

Revenues in US million Dollars

*t is used to treat i' %olesterol and related%onditions and to "reent%ardioas%ular disease/

+restor is te #ourti'est sellin' dru' in teUnited States a%%ountin' #or a""ro/ $5/2

billion in sales in 2013/

https://en.wikipedia.org/wiki/Hypercholesterolemiahttps://en.wikipedia.org/wiki/Cardiovascular_diseasehttps://en.wikipedia.org/wiki/Cardiovascular_diseasehttps://en.wikipedia.org/wiki/Hypercholesterolemia


12/23

REMICADE

2012 20137000

7100

7200

7300

7400

7500

7600

7700

7800

7259

7678

Remicade Salesemi%ade is used to treatrheumatoid arthritis. *t is also used totreat rohn!s disease orulcerative colitis.

"atent holder# onson onson

• *n te United States remi%ade %an%ost $19000 to $22000 a !ear "er"atient/

• onson onson re"orted in its

2013 annual re"ort E*+.E(in#liimab) a%%ounted #ora""roimatel! 9/4 o# te +om"an!:stotal reenues #or #is%al 2013/

http://www.drugs.com/mcd/rheumatoid-arthritishttp://www.drugs.com/mcd/crohn-s-diseasehttp://www.drugs.com/mcd/crohn-s-diseasehttp://www.drugs.com/mcd/ulcerative-colitishttp://www.drugs.com/mcd/ulcerative-colitishttp://www.drugs.com/mcd/crohn-s-diseasehttp://www.drugs.com/mcd/crohn-s-diseasehttp://www.drugs.com/mcd/rheumatoid-arthritis


13/23

e/ium;eium (esome"ra


14/23

MABTHERA

*t %onsist o# Ritu$imab >i% isan anti%an%er dru'

mole%ule

?@AE is usedto treat nonAod'&inBs l!m"oma

and %roni%l!m"o%!ti%leu&aemia/

2012 20135700

5800

5900

6000

6100

6200

6300

5950

6263

'abhera sales in *+,

Sales (US $ million)


15/23

2011 2012 2013 20140

1000

2000

3000

4000

5000

6000

7000

54295950

6363 6552

'abthera


16/23

Indian Therae!"i#Se$%en"&


17/23

Top 20 Global Therapeutic Categories


18/23

P&AMA'#*'A+ ',MPA*S


19/23

$lo%al $enericmar.et

Sales

;ort meri%a

Euro"e

?ra


20/23


21/23

stimates

• According to I'S -ealth spending on medicines will reachnearly /++** billion in *+0 with a growth rate of ,#1 percentover the last five#year period.

• he overall outloo2 of the global pharma industry in *+0 andbeyond is e$pected to be as follows3

• A dozen products launched in *+0 are forecast to achievebloc2buster sales by **

• 4rugs treating high cholesterol and heart failure will dominatethe field with a combined ** sales forecast of 5S/6 billion

• Sovaldi and its combination product -arvoni will ta2e thenumber one worldwide seller spot with forecasted sales of/+0., billion in *+0

•


22/23

EDEE;+ES

• tt"C>>>/business>ee&/%ominestor%

ontentma!2009"i2009051F087752/tm• tt"C>>>/ta"anra!/in"armaoutloo&201

5a'lim"seo#somedriersandbarriers

• tt"C>>>/statista/%omstatisti%s318206reenueo#umira

• >>>/dru's/%om

http://www.businessweek.com/investor/content/may2009/pi2009051_087752.htmhttp://www.businessweek.com/investor/content/may2009/pi2009051_087752.htmhttp://www.tapanray.in/pharma-outlook-2015-a-glimpse-of-some-drivers-and-barriershttp://www.tapanray.in/pharma-outlook-2015-a-glimpse-of-some-drivers-and-barriershttp://www.statista.com/statistics/318206/revenue-of-humira/http://www.statista.com/statistics/318206/revenue-of-humira/http://www.statista.com/statistics/318206/revenue-of-humira/http://www.statista.com/statistics/318206/revenue-of-humira/http://www.tapanray.in/pharma-outlook-2015-a-glimpse-of-some-drivers-and-barriershttp://www.tapanray.in/pharma-outlook-2015-a-glimpse-of-some-drivers-and-barriershttp://www.businessweek.com/investor/content/may2009/pi2009051_087752.htmhttp://www.businessweek.com/investor/content/may2009/pi2009051_087752.htm


23/23

Best Selling Pharma Products in 2014-15

Documents

Transcript of Best Selling Pharma Products in 2014-15